Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks65WK.L Regulatory News (65WK)

  • There is currently no data for 65WK

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue 623 amended and restated

7 Oct 2021 13:12

RNS Number : 3689O
Santander UK Plc
07 October 2021
 

Company Announcement

For immediate release

 

SANTANDER UK PLC

 

AMENDED AND RESTATED FINAL TERMS

 

The following amended and restated final terms (the "Amended and Restated Final Terms") are available for viewing:

 

Amended and Restated Final Terms relating to issue of USD 2,000,000 Inflation Linked Interest Bearing Notes due March 2022 (the "Notes") (originally issued by Abbey National Treasury Services plc and guaranteed by Santander UK plc) ISIN XS0762975257

under the €10,000,000,000 Structured Note Programme (the "Programme").

To view the full Amended and Restated Final Terms document, please click on or paste the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/3689O_1-2021-10-7.pdf

A copy of the above Amended and Restated Final Terms has been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

The Final Terms can also be viewed at: https://www.santander.co.uk/about-santander/investor-relations/santander-uk-notes-certificates-programme.

 

For any further information, please contact:

Structured Notes Desk

Tel: +44 (0) 20 7756 7000 or structurednotesafm@santander.co.uk.

 

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Amended and Restated Final Terms and the base prospectus relating to the Programme (the "Base Prospectus") may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus and/or the Amended and Restated Final Terms) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectus and/or the Amended and Restated Final Terms is not addressed. Prior to relying on the information contained in the Base Prospectus and/or the Amended and Restated Final Terms, you must ascertain from the Base Prospectus and/or the Amended and Restated Final Terms whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement.

Neither the Base Prospectus nor the Amended and Restated Final Terms referenced herein constitute an offer of securities for sale in the United States. The securities described herein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or under any relevant securities laws of any state of the United States of America, and may not be offered or sold to U.S. persons or to persons within the United States of America, except pursuant to an exemption from the Securities Act.

 

END

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFTBGBDGIDGDGBR
12
Date   Source Headline
7th Apr 20223:22 pmRNSPublication of Final Terms
1st Apr 20226:15 pmRNSResult of AGM
22nd Mar 20224:43 pmRNSPublication of Final Terms
7th Mar 202210:08 amRNSCovered Bond Programme - Publication of Prospectus
2nd Mar 20227:15 amRNSAnnual Financial Report
2nd Mar 20227:15 amRNSAnnual Financial Report
2nd Feb 20221:58 pmRNSPublication of Suppl.Prospcts
2nd Feb 20221:46 pmRNSSupplemental Prospectus
2nd Feb 20227:15 amRNSQuarterly Management Statement - Q4 2021
21st Jan 20221:26 pmRNSArticle 17 notification - Issue 1197
21st Jan 20221:24 pmRNSArticle 17 notification - Issue 1196
21st Jan 20221:24 pmRNS1195 LSE Cancellation Announcement
5th Jan 20222:23 pmRNSNotice of Early Redemption
24th Dec 20218:47 amRNSIntention To Exercise Regulatory Call
23rd Dec 20211:55 pmRNS1193 Cancellation Announcement
10th Dec 20211:28 pmRNSARTICLE 17 NOTIFICATION - Issue 1194
6th Dec 20219:05 amRNSSantander UK - Board Changes
29th Nov 20217:00 amRNSDirectorate Change
1st Nov 20217:00 amRNSSupplemental Prospectus
1st Nov 20217:00 amRNSSupplemental Prospectus
29th Oct 20215:23 pmRNSAMENDMENTS TO COVERED BOND SWAPS
27th Oct 20217:15 amRNSQuarterly Management Statement - Q3 2021
18th Oct 20211:35 pmRNS1191 Cancellation Announcement
18th Oct 202111:11 amRNSIssue 1192 Article 17 notification
7th Oct 20211:12 pmRNSIssue 623 amended and restated
1st Oct 202111:33 amRNSDirectorate Change
21st Sep 20213:08 pmRNSTender Offer - Results
20th Sep 202112:28 pmRNSTender Offer Results
17th Sep 20215:08 pmRNSSantander UK plc Tender Offer Pricing
13th Sep 20211:48 pmRNSSantander UK plc Tender Offer
13th Sep 20219:25 amRNSSantander UK plc Tender Offer
23rd Aug 20211:24 pmRNSArticle 17 Notification - 1189 (ISIN XS2352402387)
16th Aug 20211:53 pmRNSSantander UK plc - Board Change
13th Aug 20213:22 pmRNSSupplementary Prospectus EMTN Programme
13th Aug 20217:15 amRNSHalf-year Report - 30 June 2021
28th Jul 20213:36 pmRNSSupplemental Prospectus
28th Jul 20217:15 amRNSQ2 2021 Results and Board Change
16th Jul 20211:42 pmRNSNOTICE OF EARLY REDEMPTION - ISIN: XS2359958241
12th Jul 20211:30 pmRNSIssue 1187 XS2326323305 Article 17 notification
2nd Jul 20219:04 amRNSPart VII Banking Business Transfer Scheme
21st Jun 20214:30 pmRNSPricing Announcement
21st Jun 20213:55 pmRNSFinal Results of Tender Offer
21st Jun 202112:52 pmRNSEarly Results Announcement
21st Jun 202110:17 amRNSIndicative Results Announcement (non-US Offer)
14th Jun 20218:32 amRNSTender Offer
7th Jun 20212:57 pmRNSCash Tender Offers for two series of Notes
1st Jun 20217:00 amRNSArticle 17 Notification - 1185 (ISIN XS2294359570)
12th May 20214:17 pmRNSPublication of Prospectus
12th May 20214:13 pmRNSPublication of Prospectus
30th Apr 20216:20 pmRNSPublication of Supplementary Prospectus
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.